ストックスクリーナーアプリを入手
1.59
1.59%
0.02
前日終値:
$1.57
開ける：
$1.57
24時間の取引高:
137.22K
Relative Volume:
0.25
時価総額：
$167.54M
収益：
$17.91M
当期純損益:
$-47.66M
株価収益率:
-3.4976
EPS:
-0.4546
ネットキャッシュフロー:
$-62.63M
1週間 パフォーマンス:
+11.54%
1か月 パフォーマンス:
+7.05%
6か月 パフォーマンス:
-32.42%
1年 パフォーマンス:
-6.18%
1日の値動き範囲:
$1.5404
$1.63
1週間の範囲:
$1.42
$1.64
52週間の値動き範囲:
$1.33
$3.10
Proqr Therapeutics N V Stock (PRQR) Company Profile
Compare PRQR vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PRQR
Proqr Therapeutics N V
|
1.5901 | 165.42M | 17.91M | -47.66M | -62.63M | -0.4546 |
VRTX
Vertex Pharmaceuticals Inc
|
442.19 | 110.64B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
630.88 | 66.53B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
823.05 | 50.27B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
294.80 | 39.45B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
152.44 | 32.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Proqr Therapeutics N V Stock (PRQR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-12 | 再開されました | Oppenheimer | Outperform |
| 2025-04-29 | 再開されました | Cantor Fitzgerald | Overweight |
| 2025-04-29 | 開始されました | Evercore ISI | Outperform |
| 2025-03-10 | アップグレード | Citigroup | Neutral → Buy |
| 2025-01-10 | 開始されました | Oppenheimer | Outperform |
| 2024-10-29 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2023-11-08 | アップグレード | Chardan Capital Markets | Neutral → Buy |
| 2023-03-30 | アップグレード | JMP Securities | Mkt Perform → Mkt Outperform |
| 2022-12-22 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2022-02-14 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-02-11 | ダウングレード | Raymond James | Strong Buy → Mkt Perform |
| 2022-02-11 | ダウングレード | Stifel | Buy → Hold |
| 2022-02-01 | 開始されました | Raymond James | Strong Buy |
| 2021-05-03 | 開始されました | Stifel | Buy |
| 2021-03-25 | 繰り返されました | Citigroup | Buy |
| 2020-11-03 | 再開されました | Cantor Fitzgerald | Overweight |
| 2019-03-12 | 繰り返されました | Chardan Capital Markets | Buy |
| 2018-12-19 | 開始されました | RBC Capital Mkts | Outperform |
| 2018-11-15 | 開始されました | Citigroup | Buy |
| 2018-09-19 | 開始されました | Evercore ISI | Outperform |
| 2017-09-26 | 繰り返されました | JMP Securities | Mkt Outperform |
| 2016-06-20 | 開始されました | Chardan Capital Markets | Neutral |
| 2014-10-15 | 開始されました | Deutsche Bank | Buy |
| 2014-10-13 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Proqr Therapeutics N V (PRQR) 最新ニュース
Citizens reiterates ProQR stock rating on biliary atresia potential - Investing.com
ProQR (PRQR) Eyes Next Move After Holiday Ahead of AX-0810 Data - Bez Kabli
ProQR Therapeutics Q1 2026 Earnings: Narrower Net Loss, No Revenue as Pipeline Progress Drives Stock GainsWall Street Picks - Newser
Cash per share of ProQR Therapeutics N.V. – LS:A12B97 - TradingView
PRQR Stock Price, Quote & Chart | PROQR THERAPEUTICS NV (NASDAQ:PRQR) - ChartMill
ProQR Therapeutics N.V. (PRQR) Presents at 29th ASGCT Annual Meeting 2026Slideshow - Seeking Alpha
ProQR Therapeutics N.V. (PRQR) Presents at TIDES USA 2026Slideshow (NASDAQ:PRQR) 2026-05-15 - Seeking Alpha
ProQR Therapeutics N.V.Ordinary Shares (NQ: PRQR - The Chronicle-Journal
ProQR Therapeutics N.V. (NASDAQ:PRQR) Analysts Just Slashed This Year's Revenue Estimates By 22% - Yahoo Finance
ProQR Therapeutics Releases Q1 2026 Financial Results - AlphaStreet
ProQR Posts Q1 2026 Results as Axiomer RNA Editing Pipeline Advances - TipRanks
ProQR Posts Wider Q1 2026 Loss but Maintains Strong Cash Position - TipRanks
ProQR Announces First Quarter 2026 Operating and Financial Results - The Manila Times
ProQR (Nasdaq: PRQR) Q1 2026 results, Axiomer pipeline and cash runway - Stock Titan
ProQR (Nasdaq: PRQR) updates AX-0810 strategy and Q1 2026 results - Stock Titan
ProQR Therapeutics N.V. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
ProQR Announces Multiple Upcoming Scientific Conference Presentations Highlighting the Breadth of its Axiomer™ RNA Editing Platform - The Manila Times
ProQR Announces Multiple Upcoming Scientific Conference - GlobeNewswire
MSN Money - MSN
Number of shareholders of ProQR Therapeutics N.V. – LS:A12B97 - TradingView
ProQR Therapeutics (PRQR) to Release Quarterly Earnings on Thursday - MarketBeat
ProQR Sets June 2, 2026 Date for Annual General Meeting of Shareholders - The Globe and Mail
ProQR forms advisory board, partnership with Ginkgo as part of AI strategy - MSN
ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026 - markets.businessinsider.com
ProQR Therapeutics NV expected to post a loss of 12 cents a shareEarnings Preview - TradingView
ProQR Therapeutics N : AGM 2026 POA Registered Shareholders - marketscreener.com
ProQR sets June 2 shareholder meeting, posts agenda documents online - Stock Titan
ProQR (PRQR) 2026 AGM to expand share capital, issuance and buyback powers - Stock Titan
ProQR Announces Annual General Meeting of Shareholders to Be Held June 2, 2026 - Moomoo
ProQR Nominates Boehringer Ingelheim CMO Lykke Hinsch Gylvin to Board to Support Next Growth Phase - The Globe and Mail
ProQR nominates Boehringer Ingelheim executive to board - Investing.com UK
ProQR nominates Boehringer Ingelheim executive to board By Investing.com - Investing.com Australia
Boehringer exec tapped for ProQR (NASDAQ: PRQR) board nomination - Stock Titan
ProQR Announces Nomination of Dr. Lykke Hinsch Gylvin to its Board of Directors - GlobeNewswire
ProQR Therapeutics N.V. (NASDAQ:PRQR) Short Interest Down 24.4% in April - MarketBeat
ProQR Therapeutics NV (MEX:PRQRN) Stock News, Headlines & Updates - GuruFocus
ProQR Therapeutics NV (MEX:PRQRN) Stock Price & 30 Year Financial Data - GuruFocus
Chardan Capital Maintains ProQR Therapeutics N.V. (PRQR) Buy Recommendation - MSN
ProQR Therapeutics N.V. (NASDAQ:PRQR) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
ProQR Therapeutics (NASDAQ:PRQR) Stock Price Passes Above 50 Day Moving AverageShould You Sell? - MarketBeat
Proqr Therapeutics N V (PRQR) 財務データ
収益
当期純利益
現金流量
EPS
0.67%
1.91%
大文字化:
|
ボリューム (24 時間):